Familial Hypertrophic Cardiomyopathy Mice Display Gender Differences in Electrophysiological Abnormalities

Journal of Interventional Cardiac Electrophysiology

Volumn 2, Issue 1, 1997, Pages 7-14

  Berul, Charles I ^a,c,d   Christe, Michael E ^b   Aronovitz, Mark J ^a   Maguire, Colin T ^a   Seidman, Christine E ^b,c   Seidman, J G ^b,c   Mendelsohn, Michael E ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Electrophysiology; Gender; Hypertrophic cardiomyopathy; Mouse models; Ventricular tachycardia

Indexed keywords

EID: 2342629404     PISSN: 1383875X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009700404218     Document Type: Article

References (29)

1. Seidman CE, Seidman JG. Gene mutations that cause familial hypertrophic cardiomyopathy. In: Haber E, ed. Molecular Cardiovascular Medicine. New York: Scientific American Press, 1995;193-210.
2. Watkins H, McKenna W, Thierfelder L, Suk HJ, Anan R, O'Donoghue A, Spirito P, Matsumori A, Moravec CS, Seidman JG, Seidman CE. Mutations in the genes for cardiac troponin T and α-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med 1995;332:1058-1064.
3. Geisterfer-Lowrancen AAT, Christe ME, Conner D, Ingwall J, Schoen F, Seidman CE, Seidman JG. A mouse model of familial hypertrophic cardiomyopathy. Science 1996;272: 732-734.
4. Berul CI, Aronovitz MJ, Wang PJ, Mendelsohn ME. In vivo cardiac electrophysiology studies in the mouse. Circulation 1996;94:2641-2648.
5. Berul CI, Christe ME, Aronovitz MJ, Seidman CE, Seidman JG, Mendelsohn ME. Electrophysiological abnormalities and arrhythmias in α-MHC mutant familial hypertrophic cardiomyopathy mice. J Clin Invest 1997;99:274-280.
6. Bazett HC. An analysis of the time relationships of the heart. Heart 1920;7:353-370.
7. Berul CI, Sweeten TL, Dubin AM, Shah MJ, Vetter VL. Use of the rate-corrected JT interval for prediction of repolarization abnormalities in children. Am J Cardiol 1994;74: 1254-1257.
8. Gillette PC, Buckles DC, Harold H, Garson A. Intracardiac electrophysiology studies. In: Gillette PC, Garson A, eds. Pediatric Arrhythmias: Electrophysiology and Pacing. Philadelphia: WB Saunders, 1990;216-248.
9. Roberts NK, Gillette PC. Electrophysiologic study of the conduction system in normal children. Pediatrics 1997;60: 868-863.
10. Kugler JD. Electrophysiology studies. In: Emmanouilides GC, Reimenschneider TA, Allen HD, Gutgesell HP, eds. Moss and Adams' Heart Disease in Infants, Children, and Adolescents, including the Fetus and Young Adult. Baltimore: Williams & Wilkins, 1995;347-366.
11. Mandel W, Hayakawa H, Danzig R, Marcus HS. Evaluation of sino-atrial node function in man by overdrive suppression. Circulation 1971;44:59-66.
12. Zipes DP. Specific arrhythmias: diagnosis and treatment. In: Braunwald E, ed. Heart disease: A Textbook of Cardiovascular Medicine. Philadelphia: WB Saunders, 1992; 667-725.
13. Vetter VL. The pediatric electrophysiology study. In: Leibman J, Plonsey R, Rudy Y, eds. Pediatric and Fundamental Electrocardiography. New York: Martinus Nijhoff, 1985; 161-184.
14. Fananapazir L, Chang AC, Epstein SE, McAreavy D. Prognostic determinants in hypertrophic cardiomyopathy: prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings. Circulation 1992;86:730-740.
15. Epstein ND, Cohn GM, Cyran F, Fananapazir L. Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in α-myosin heavy chain gene. Circulation 1992;86:345-352.
16. Buja G, Miorelli M, Turrini P, Melacini P, Nava A. Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death. Am J Cardiol 1993; 72:973-976.
17. Wigle ED, Rakowski H, Kimball BP, Williams WG. Hypertrophic cardiomyopathy: clinical spectrum and treatment. Circulation 1995; 92:1680-1692.
18. Fananapazir L, Epstein SE. Hemodynamic and electrophysiologic evaluation of patients with hypertrophic cardiomyopathy surviving cardiac arrest. Am J Cardiol 1991; 67:280-287.
19. Maron BJ, Fananapazir L. Sudden cardiac death in hypertrophic cardiomyopathy. Circulation 1992; 85:I57-63.
20. Watson RM, Schwartz JL, Maron BJ, Tucker E, Rosing DR, Josephson ME. Inducible polymorphic ventricular tachycardia and ventricular fibrillation in a subgroup of patients with hypertrophic cardiomyopathy at risk for sudden death. J Am Coll Cardiol 1987; 10:761-774.
21. Scheidt S. Basic electrocardiography: abnormalities of electrocardiographic patterns. Clinical Symposia 1984; 36:2-32.
22. Karas RH, Baur WE, Mendelsohn ME. Human vascular smooth muscle cells express a novel estrogen receptor isoform. Circulation 1994; 90:462-469.
23. Sullivan TR Jr, Karas RH, Aronovitz M, Faller GT, Ziar JP, Smith JJ, O'Donnell TF Jr, Mendelsohn E. Estrogen inhibits the response-to-injury in a mouse carotid artery model. J Clin Invest 1995; 96:2482-2488.
24. Iafrati MD, Karas RH, Aronovitz M, Kim S, Sullivan TR Jr, Lubhan DB, O'Donnell TF Jr, Korach KS, Mendelson ME. Estrogen inhibits the vascular injury response in estrogen receptor α-deficient mice. Nature Medicine 1997; 3:545-548.
25. +2 in guinea-pig isolated cardiac myocytes. Br J Pharmacol 1982; 106:739-745.
26. Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, Moncada S. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci USA 1994; 91:5212-5216.
27. Mershon JI, Mikala G, Schwartz A. Changes in expression of the L-type voltage-dependent calcium channel during pregnancy and parturition in the rat. Biol Reproduction 1994; 51:993-999.
28. 2+ currents in aortic smooth muscle cells. Eur J Pharmacol 1995; 294:625-635. 1995.
29. Watkins H, Rosenweig A, Hwang D, Levi T, McKenna W, Seidman CE, Seidman JG. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med 1992; 326:1108-1114.